iNCOVACC, on Tuesday, became the world's first intra-nasal vaccine to receive both Primary series and Heterologous booster approval, Bharat Biotech International Limited (BBIL) announced
A novel nasal vaccination method has been created by researchers from the Centenary Institute and the University of Sydney that promotes strong lung immunity and protection against the SARS-CoV-2 coronavirus.
Diminishing air quality in the national capital is affecting children up to 16 years of age more as compared to the adults. The pediatric population is suffering from frequent exacerbation, asthma, allergies, nasal blockage, allergic rhinitis and mental problems.
New Delhi [India], September 14 (ANI): The OPS/NPS specimen as well as possibly urine specimens should be considered as critical specimens for Monkeypox diagnosis in cases with no active skin lesions, according to a study.
New Delhi [India], September 6 (ANI): The Drugs Controller General of India (DCGI) rendered an emergency use authorization (EUA) to Bharat Biotech for the intranasal vaccine- iNCOVACC, said officials on Tuesday.
New Delhi [India], September 6 (ANI): The Bharat Biotech on Tuesday got emergency use authorisation from the Drugs Controller General of India (DCGI) for the Intranasal Covid-19 vaccine.
New Delhi [India], September 5 (ANI/PNN): Sinusitis is a common condition defined as inflammation of the paranasal sinuses, the cavity within the bones that surround the nose. The inflammation leads to oedema and blockade of airflow and causes the secretion of fluid into the sinus cavities,
London [UK]/ Mahwah (New Jersey) [US], Mumbai (Maharashtra) [India], August 31 (ANI/PRNewswire): Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical company, and Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd. (Glenmark) - an innovation driven gl
Mumbai (Maharashtra) [India]/ Vancouver [BC], July 13 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company, and SaNOtize Research and Development Corp, today announced that The Lancet Regional Health Southeast Asia (TLRHSEA) - pee
Cambridge [England], July 9 (ANI): A recent study found that male dogs are four to five times more likely than female dogs to develop the oro-nasal variant of a canine transmissible venereal tumour.
Cambridge [England], July 4 (ANI): According to a recent study, male dogs have a four to five times higher chance of contracting the oro-nasal variant of canine transmissible venereal tumour than female dogs.